Medical Innovation Exchange

Curis gets FDA green light to restart lymphoma trial, though partial hold on leukemia study stays in place

https://www.fiercebiotech.com/biotech/curis-gets-green-light-fda-lifts-clinical-hold-lymphoma-trial-though-partial-hold-leukemia

Leave a Comment

Your email address will not be published.

Leave the field below empty!